首页
400-620-6333
小分子和化合物库
选项
-
儿茶酚-d4CAS号: 103963-58-2分子式: C6H2D4O2 分子量: 114.14IUPAC Name: 3,4,5,6-tetradeuteriobenzene-1,2-diolSMILES: C1=CC=C(C(=C1)O)OInChIKey: YCIMNLLNPGFGHC-RHQRLBAQSA-NInChI: 1S/C6H6O2/c7-5-3-1-2-4-6(5)8/h1-4,7-8H/i1D,2D,3D,4D
-
尿苷-5,6-d2CAS号: 40632-21-1分子式: C9H10D2N2O6 分子量: 246.21IUPAC Name: 5,6-dideuterio-1-[(2R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dioneSMILES: C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)OInChIKey: DRTQHJPVMGBUCF-TTYVMISXSA-NInChI: 1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6+,7?,8-/m1/s1/i1D,2D
-
25-羟基维生素 D₂ (6,19,19-d₃)CAS号: 1217467-39-4 Compound CID : 71310751分子式: C28D3H41O2 分子量: 415.67IUPAC Name: (1S,3E)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]-1-deuterioethylidene]-4-(dideuteriomethylidene)cyclohexan-1-olSMILES: [2H]/C([2H])=C1CC[C@H](O)CC\1=C([2H])\C=C2/CCC[C@]3(C)[C@H](CC[C@@H]23)[C@H](C)\C=C\[C@H](C)C(C)(C)OInChIKey: KJKIIUAXZGLUND-ABHIMYCLSA-NInChI: See more
-
D-葡萄糖-¹³C₆,1,2,3,4,5,6,6-d₇CAS号: 201417-01-8分子式: 13C6H5D7O6 分子量: 193.15IUPAC Name: (2R,3S,4R,5R)-1,2,3,4,5,6,6-heptadeuterio-2,3,4,5,6-pentahydroxy(1,2,3,4,5,6-13C6)hexan-1-oneSMILES: C(C(C(C(C(C=O)O)O)O)O)OInChIKey: GZCGUPFRVQAUEE-VVZLUFAVSA-NInChI: 1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h1,3-6,8-12H,2H2/t3-,4+,5+,6+/m0/s1/i1+1D,2+1D2,3+1D,4+1D,5+1D,6+1D
-
L-丙氨酸-¹³C₃,¹⁵NCAS号: 202407-38-3分子式: 13CH313CH(15NH2)13CO2H 分子量: 93.06IUPAC Name: (2S)-2-(15N)azanyl(1,2,3-13C3)propanoic acidSMILES: CC(C(=O)O)NInChIKey: QNAYBMKLOCPYGJ-UVYXLFMMSA-NInChI: 1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1/i1+1,2+1,3+1,4+1
-
Belantamab mafodotin (anti-BCMA)关联靶标: TNFRSF17简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAF)种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: MC-VC-PAB-MMAFCAS号: 2050232-20-5SMILES: [Belantamab mafodotin]
-
Lifastuzumab vedotin (anti-SLC34A2)关联靶标: SLC34A2简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: MC-VC-PAB-MMAECAS号: 1401812-88-1
-
Lorvotuzumab mertansine (anti-NCAM1)关联靶标: NCAM1简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (SMCC-DM1)种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: SMCC-DM1CAS号: 1008106-64-6
-
Lutikizumab (anti-IL1a&IL1b)简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1791411-57-8
-
Labetuzumab govitecan (anti-CEACAM5)关联靶标: CEACAM5简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (CL2A-SN-38)种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: CL2A-SN-38CAS号: 1469876-18-3 Compound CID : 91668184SMILES: See more
-
Ozoralizumab (anti-TNF-alpha&HSA)简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human)宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1167985-17-2
-
Sacituzumab govitecan (anti-TROP2)关联靶标: TACSTD2简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Conjugated (Mc-VC-PAB-SN38)种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: Mc-VC-PAB-SN38CAS号: 1491917-83-9SMILES: [Sacituzumab govitecan]
